Needham & Company Upgrades Constant Contact (CTCT) to Buy; Some Social Marketing Light At The End of the Tunnel
Get Alerts CTCT Hot Sheet
Price: $32.01 --0%
Rating Summary:
2 Buy, 13 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
2 Buy, 13 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Needham & Company upgraded Constant Contact (NASDAQ: CTCT) from Hold to Buy. PT $29.
Needham analyst says, "We are upgrading our rating on CTCT shares primarily to reflect overstated negativity around nearer-term trends and our increased enthusiasm over the upcoming Social Marketing product cycle (which should launch by year end). Although we still acknowledge that competitive Freemium offerings (including MailChimp and iContact) along with typical summer seasonality could constrain netadd growth and negatively impact cost of acquisition (COA) over the next couple quarters, we believe that the prevailing negative sentiment already reflects this scenario."
For more ratings news on Constant Contact click here and for the rating history of Constant Contact click here.
Shares of Constant Contact closed at $23.91 yesterday.
Needham analyst says, "We are upgrading our rating on CTCT shares primarily to reflect overstated negativity around nearer-term trends and our increased enthusiasm over the upcoming Social Marketing product cycle (which should launch by year end). Although we still acknowledge that competitive Freemium offerings (including MailChimp and iContact) along with typical summer seasonality could constrain netadd growth and negatively impact cost of acquisition (COA) over the next couple quarters, we believe that the prevailing negative sentiment already reflects this scenario."
For more ratings news on Constant Contact click here and for the rating history of Constant Contact click here.
Shares of Constant Contact closed at $23.91 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Needham Reiterates Buy Rating on Bill.com Holdings Inc. (BILL)
- Needham on Klarna (KLAR): 'Shares Back to the Penalty Box'
Create E-mail Alert Related Categories
UpgradesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share